Parameter
| Biomarker | PGE2 | Full name | Prostaglandin E2 | Molecular Type | Lipid |
|---|---|---|---|---|---|
| Molecular Formula | C20H32O5 | Molecular Weight | 352.47 g/mol | Core Functional Dimensions | Diagnosis, prognosis |
| Disease | BPH | Disease Subtypes | / | ||
| Organ | Prostate | Test Sample / Technology Platform | Urine (ELISA) | ||
| Pathobiological Mechanisms | Catalyzed by cyclooxygenase to produce arachidonic acid, it is a key pro-inflammatory factor. In benign prostatic hyperplasia (BPH), it is closely associated with inflammatory, edematous, and fibrotic processes in prostate and bladder tissues. | ||||
| Clinical Availability Status | Research verification | ||||
| Notes and Dynamics | The results showed that the baseline level of the surgical group was higher and decreased significantly after surgery, suggesting that it was closely related to mechanical obstruction and subsequent inflammation. | ||||